LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Recruiting

• Conditions: Chronic Leukemia; Prostate Cancer; Ovarian Cancer; Lung Cancer; Cancer; Breast Cancer; Multiple Myeloma; Colorectal Cancer; Tyrosine Kinase Mutation; Melanoma

• Registration Number: NCT05645510
• Lead Sponsor: University of Alberta

Brief Summary

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Detailed Description

Participants ill be scheduled for an in-person, telephone or computer video interview with the researcher(s). They will be asked about their experiences receiving targeted anti-cancer treatments. Then over the next 3 months, participants will be asked to think about how receiving these cancer treatments affects daily living and to create a 'metaphor'. Metaphors may be composed with any mix of visual, verbal, musical or other works participants feel expresses and brings their experiences to life.

Study Timeline

• Study Start: 2022-11-24
• Study First Submitted: 2022-11-30
• Study First Submitted QC: 2022-11-30
• Study First Posted: 2022-12-09
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-14
• Last Update Posted: 2025-04-15
• Primary Completion: 2025-11-30
• Study Completion: 2026-05-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

taking chronic targeted anti-cancer agents -

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interview	3 months	Interview to learn the experiences of people living with incurable cancers

Trial Locations

Locations (1)

Edith Pituskin; 🇨🇦 Edmonton, Alberta, Canada